Principal component analysis of early immune cell dynamics during pembrolizumab treatment of advanced urothelial carcinoma.

Teshima, Taro; Kobayashi, Yukari; Kawai, Taketo; Kushihara, Yoshihiro; Nagaoka, Koji; Miyakawa, Jimpei; Akiyama, Yoshiyuki; Yamada, Yuta; Sato, Yusuke; Yamada, Daisuke; Tanaka, Nobuyuki; Tsunoda, Tatsuhiko; Kume, Haruki; Kakimi, Kazuhiro.

Afiliação

Teshima T; Department of Urology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Kobayashi Y; Department of Immunotherapeutics, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Kawai T; Department of Immunotherapeutics, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Kushihara Y; Department of Urology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Nagaoka K; Department of Immunotherapeutics, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Miyakawa J; Department of Immunotherapeutics, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Akiyama Y; Department of Urology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Yamada Y; Department of Urology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Sato Y; Department of Urology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Yamada D; Department of Urology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Tanaka N; Department of Urology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Tsunoda T; Department of Urology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Kume H; Department of Biological Sciences, School of Science, The University of Tokyo, Tokyo 113-0033, Japan.
Kakimi K; Laboratory for Medical Science Mathematics, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa 230-0045, Japan.